Navigation Links
DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma
Date:3/31/2008

g

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company

and its officers and directors and any proposed settlement of such

litigation;

-- the Company's ability to retain compliance with the NASDAQ's listing

qualifications; and

-- the other risks described under Certain Risks and Uncertainties

Related to the Company's Business, as contained in the Company's

Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2007 and its most recent quarterly report on Form 10-Q.

CONTACT:

Nichol Harber

Genta Investor Relations

908-286-3980

info@genta.com


'/>"/>
SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
2. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
3. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
4. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
5. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
8. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
9. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
10. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
11. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... coil is used to treat an unruptured and ... artery wall). The treatment is either known as ... procedure, the endovascular coil blocks the blood flow ... usually performed under general anaesthesia by an interventional ...
(Date:9/2/2015)... 2015 Advanced Wound Dressings - 5EU ... dressings have steadily replaced traditional bandages and gauze ... wound indications, such as trauma wounds, burns, and ... physical protection become increasingly critical in wound healing, ... therapy. This report focuses on nine market ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015   ... of the most common laboratory technologies that is used ... and antibodies in solution. ELISA test uses various types ... alkaline phosphatases and the result is detected by photometry ... in the treatment of various infectious diseases such as ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
... May 3, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... 2011. For the first quarter of 2011, Rigel reported ... to a net loss of $22.3 million, or $0.43 per share, ... the first quarter of 2011 and 2010 were 52.3 million and ...
... Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical ... today announced dosing of the first patient in a ... cenderitide.  The trial is being conducted pursuant to Nile,s ... clinical step towards developing cenderitide as a treatment for ...
Cached Medicine Technology:Rigel Announces First Quarter Financial Results 2Rigel Announces First Quarter Financial Results 3Rigel Announces First Quarter Financial Results 4Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 2Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 3
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... their team will be participating at the highly anticipated Mississippi Gulf Babypalooza on ... mothers coming from all over, from Gulfport, Biloxi, and beyond. We will be ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
(Date:9/3/2015)... ... ... Earl Jones will be hosting an upcoming VOICES IN AMERICA segment that highlights the ... that discusses why it is important for the workplace to be healthier, the effects ... environment. , Employers are out billions of dollars year after year due to sick ...
(Date:9/3/2015)... ... 2015 , ... The partnership will leverage Fidson’s strong and ... to promote LodonalTM in Nigeria. The distribution will become effective, upon completion of ... the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed that ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... listed among the most influential leaders in healthcare, will offer the keynote address ... take place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
... ... information on sexual health and sexual medicine easily accessible to the public and to ... TWSHF board of directors voted to dissolve the non-profit and donate its assets to ... ...
... , , , ... scientist M. Elizabeth "Betz" Halloran, M.D., M.P.H., D.S.c., has been awarded ... honor bestowed upon members of the American Association for the Advancement ... researcher in the Hutchinson Center,s Vaccine and Infectious Disease Institute and ...
... , LOS ANGELES, Dec. 17 ... and Energy-X lip balms, today announced the launch of ... heating/cooling treatment packs are specifically designed to reduce swelling ... variety of applications. Researchers behind Thermal-Aid created a line ...
... , Charmaine Yoest Urges "Comprehensive Respect for Life" in ... , WASHINGTON, Dec. 17 Americans United for Life Action President, ... Harry Reid as he considers a manager,s amendment - the Majority ... bill. The letter urges Senator Reid to include "specific language that ...
... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
... fall down on prevention, experts say , THURSDAY, Dec. ... getting better at treating heart attacks and other cardiovascular ... for preventing them, according to new statistics from the ... exercise, too much weight. , In fact, 59 percent ...
Cached Medicine News:Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 2Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 3Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Severe revision options for the knee and hip...
Medicine Products: